The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 26, 2005

Filed:

Nov. 26, 2001
Applicants:

Jim Mcwhir, Midlothian, GB;

Joseph D. Gold, San Francisco, CA (US);

J. Michael Schiff, Menlo Park, CA (US);

Inventors:

Jim McWhir, Midlothian, GB;

Joseph D. Gold, San Francisco, CA (US);

J. Michael Schiff, Menlo Park, CA (US);

Assignees:

Roslin Institute (Edinburgh), Midlothian, GB;

Geron Corporation, Menlo Park, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N001/00 ; A01N001/02 ; G01N033/53 ; C12P001/00 ; C12N015/63 ;
U.S. Cl.
CPC ...
Abstract

This invention provides a system for producing differentiated cells from a stem cell population for use wherever a relatively homogenous cell population is desirable. The cells contain an effector gene under control of a transcriptional control element (such as the TERT promoter) that causes the gene to be expressed in relatively undifferentiated cells in the population. Expression of the effector gene results in expression of a cell-surface antigen that can be used to deplete the undifferentiated cells. Model effector sequences encode glycosyl transferases that synthesize carbohydrate xenoantigen or alloantigen, which can be used for immunoseparation or as a target for complement-mediated lysis. The differentiated cell populations produced are suitable for use in tissue regeneration and non-therapeutic applications such as drug screening.


Find Patent Forward Citations

Loading…